Multispecialty - Insilico

Multispecialty

Status:

Enrolling

ClinicalTrials.gov:

NCT05975983

Phase 2A randomized doubleblinded placebo controlled study evaluating the safety and tolerability pharmacokinetics and efficacy of INS018_055 administered orally to subjects with idiopathic Pulmonary Fobrosis (IPF)

Phase

Phase 2

Condition

Idiopathic Pulmonary Fibrosis